510(k) K897133
K897133 is an FDA 510(k) premarket notification submitted by Transidyne General Corp. for the device "MODEL 1050 - UMBILICAL CORD BLOOD SAMPLING KIT". The FDA issued a decision of Substantially Equivalent on Mar 30, 1990. The device falls under product code CBT (Arterial Blood Sampling Kit), a Class I device regulated under 21 CFR 868.1100. Transidyne General Corp. has 20 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 30, 1990
- Date Received
- Dec 27, 1989
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Arterial Blood Sampling Kit
- Device Class
- Class I
- Regulation Number
- 868.1100
- Review Panel
- AN
- Submission Type
- Enforcement Discretion
This product code has been established in accordance with the may 20, 1997, guidance entitled, convenience kits interim regulatory guidance, found at www.Fda.Gov/cdrh/ode/convkit.Html. This type of convenience kit, as listed in the guidance above, is under enforcement discretion, and does not require a premarket notification (510(k)) to market if it meets all criteria in the guidance.
Need the full FDA record for Transidyne General Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.